These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16689283)

  • 1. [Kallmann syndrome].
    Fujieda K; Mukai T
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():47-53. PubMed ID: 16689283
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kallmann syndrome].
    Sato N; Ogata T
    Nihon Rinsho; 2006 Jun; Suppl 2():220-4. PubMed ID: 16817388
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
    Tsai PS; Gill JC
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolated hypogonadotropic hypogonadism].
    Shozu M
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():202-6. PubMed ID: 16689309
    [No Abstract]   [Full Text] [Related]  

  • 5. Kallmann syndrome.
    Dodé C; Hardelin JP
    Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolated gonadotropin deficiency].
    Takakura K
    Nihon Rinsho; 2006 May; Suppl 1():63-6. PubMed ID: 16776094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advances in the studies of Kallmann syndrome].
    Hao LJ; Cui YX
    Zhonghua Nan Ke Xue; 2006 Jul; 12(7):647-9. PubMed ID: 16894948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life.
    Sarfati J; Bouvattier C; Bry-Gauillard H; Cartes A; Bouligand J; Young J
    Orphanet J Rare Dis; 2015 Jun; 10():71. PubMed ID: 26051373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetics of Kallmann syndrome: an update].
    Fu C; Feng Z; Liu RZ
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.
    Dodé C; Levilliers J; Dupont JM; De Paepe A; Le Dû N; Soussi-Yanicostas N; Coimbra RS; Delmaghani S; Compain-Nouaille S; Baverel F; Pêcheux C; Le Tessier D; Cruaud C; Delpech M; Speleman F; Vermeulen S; Amalfitano A; Bachelot Y; Bouchard P; Cabrol S; Carel JC; Delemarre-van de Waal H; Goulet-Salmon B; Kottler ML; Richard O; Sanchez-Franco F; Saura R; Young J; Petit C; Hardelin JP
    Nat Genet; 2003 Apr; 33(4):463-5. PubMed ID: 12627230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix.
    Murcia-Belmonte V; Esteban PF; García-González D; De Castro F
    J Neurochem; 2010 Dec; 115(5):1256-65. PubMed ID: 20874775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
    Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
    Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical genetic testing for Kallmann syndrome.
    Layman LC
    J Clin Endocrinol Metab; 2013 May; 98(5):1860-2. PubMed ID: 23650337
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical genetics of Kallmann syndrome.
    Dodé C; Hardelin JP
    Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallmann syndrome in women: from genes to diagnosis and treatment.
    Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
    Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cysteine-rich region and the whey acidic protein domain are essential for anosmin-1 biological functions.
    Esteban PF; Murcia-Belmonte V; García-González D; de Castro F
    J Neurochem; 2013 Mar; 124(5):708-20. PubMed ID: 23189990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fertile male patient with Kallmann syndrome and two missense mutations in the KAL1 gene.
    Zhang S; Wang T; Yang J; Liu Z; Wang S; Liu J
    Fertil Steril; 2011 Apr; 95(5):1789.e3-6. PubMed ID: 21168128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.